Outstanding Loans. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company or any Subsidiary to or for the benefit of any of the officers or directors of the Company, any Subsidiary or any of their respective family members, except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof.
Appears in 6 contracts
Samples: Placement Agency Agreement, Placement Agency Agreement (Spherix Inc), Underwriting Agreement (Synergy Pharmaceuticals, Inc.)
Outstanding Loans. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company or any Subsidiary its Subsidiaries to or for the benefit of any of the officers or directors of the Company, any Subsidiary its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof.
Appears in 4 contracts
Samples: Underwriting Agreement (Evoke Pharma Inc), Underwriting Agreement (Onconova Therapeutics, Inc.), Underwriting Agreement (Evoke Pharma Inc)
Outstanding Loans. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company or any Subsidiary its Subsidiaries to or for the benefit of any of the officers or directors of the Company, any Subsidiary its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof.
Appears in 2 contracts
Samples: Underwriting Agreement (Spherix Inc), Underwriting Agreement (Spherix Inc)
Outstanding Loans. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company or any Subsidiary its Subsidiaries to or for the benefit of any of the officers or directors of the Company, any Subsidiary its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement, the Preliminary Prospectus, the General Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof.
Appears in 1 contract
Outstanding Loans. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company or any its Subsidiary to or for the benefit of any of the officers or directors of the Company, any its Subsidiary or any of their respective family members, except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof.
Appears in 1 contract
Samples: Underwriting Agreement (Cyclacel Pharmaceuticals, Inc.)